Finance

Beta
Lists
RAPP:NASDAQ
Rapport Therapeutics Inc
$35.21
-1.76%
(-0.63) 1D
$35.21
0.00% (0.00)
After hours
Closed: Jun 10, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RAPP...
Open
$35.84
High
$37.19
Low
$34.73
Mkt. cap
1.68B
Avg. vol.
295.80K
Volume
344.56K
52-wk high
$42.27
52-wk low
$10.50
EPS
-$2.60
Shares outstanding
47.83M
No. of employees
84
Open
$35.84
High
$37.19
Low
$34.73
Mkt. cap
1.68B
Avg. vol.
295.80K
Volume
344.56K
52-wk high
$42.27
52-wk low
$10.50
EPS
-$2.60
Shares outstanding
47.83M
No. of employees
84
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to RAPP in the past 3 months
Strong Buy
Buy
8
Hold
0
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for RAPP in the last 3 months.
Highest
Current $35.21
$66.00 (+87.45%)
Average
$55.71 (+58.22%)
Lowest
$46.00 (+30.64%)
News stories
From sources across the web
About Rapport Therapeutics Inc
CEO-
Employees84
Founded2022
HeadquartersBoston, Massachusetts, United States
SectorPharmaceutical industry
Websiterapportrx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
20.00M
Cost of goods sold
-
-
-
32.72M
Cost of revenue
-
-
-
32.72M
Research and development expenses
22.68M
22.28M
30.26M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.82M
7.71M
8.25M
11.50M
Operating expense
29.50M
29.99M
38.51M
11.50M
Total operating expenses
29.50M
29.99M
38.51M
44.22M
Operating income
-29.50M
-29.99M
-38.51M
-24.22M
Other non operating income
-
-
-
-
EBT including unusual items
-26.73M
-26.92M
-33.76M
-19.86M
EBT excluding unusual items
-26.73M
-26.92M
-33.76M
-19.86M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26.73M
-26.92M
-33.76M
-19.86M
Net profit margin
-
-
-
-99.28%
Earnings per share
-0.75
-0.71
-0.72
-0.42
Interest and investment income
2.76M
3.06M
4.75M
4.36M
Interest expense
-
-
-
-
Net interest expenses
2.76M
3.06M
4.75M
4.36M
Depreciation and amortization charges
-
-
-
-
EBITDA
-29.24M
-29.73M
-38.24M
-23.99M
Gain or loss from assets sale
-
-
-
153.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer